Fig. 3From: Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsClinical characteristics, cancer signaling pathway alterations, and methylation profiles of 37 FGFR3-TACC3 fusion-positive glioblastomas. Note: The variants displayed are putative drivers according to OncoKB and/or the Cancer Hotspots database [14, 15]Back to article page